On the HCPLive Lipid Management condition center page, resources on the topics of medical news and expert insight into lipidology can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dyslipidemia research, treatment, and drug development.
March 29th 2024
An analysis of the CLEAR Outcomes trial suggests bempedoic acid was well-tolerated in Hispanic/Latinx and non-Hispanic/Latinx individuals with statin intolerance.
The Heart Team at AHA 2022: Critical Care and Lipid Management, with On Chen, MD
November 8th 2022On Chen, MD, director of the Cardiac Intensive Care Unit and the Advanced Lipid Management Program at Stony Brook University, takes hosts Jorge Plutzky, MD, and Michael Farkouh, MD, on a deep dive into clinical processes at his institution and his perspective on some of the latest advances in lipid management.
ASCVD and Hypercholesterolemia: Combination Therapy and Statin Intolerance
May 30th 2022Erin D. Michos, MD, MHS; Christie Ballantyne, MD; Yehuda Handelsman, MD; and Paul S. Jellinger, MD, MACE, address the use of combination therapies and statin intolerance in patients with atherosclerotic cardiovascular disease (ASCVD) and hypercholesterolemia.
Role of Icosapent Ethyl in Managing ASCVD and Other Lipid Disorders
May 23rd 2022Matthew J. Budoff, MD; Paul S. Jellinger, MD, MACE; Erin D. Michos, MD, MHS; Yehuda Handelsman, MD; and Christie Ballantyne, MD, comment on the use of icosapent ethyl in reducing atherosclerotic cardiovascular disease (ASCVD) events and managing lipid disorders.
Utilizing Guideline Recommendations for ASCVD and Hypercholesterolemia Management
May 2nd 2022Drs Erin D. Michos, Matthew J. Budoff, Paul S. Jellinger, and Yehuda Handelsman, share their approach to incorporating guideline recommendations for the management of patients with ASCVD and hypercholesterolemia in clinical practice.
Prevalence and Risk Factors for ASCVD Associated With Hypercholesterolemia
April 25th 2022Matthew J. Budoff, MD; Christie Ballantyne, MD; and Paul S. Jellinger, MD, MACE, discuss the incidence and prevalence of atherosclerotic cardiovascular diseases (ASCVD) associated with hypercholesterolemia and risk factors for disease.